Related references
Note: Only part of the references are listed.MYC Amplification as a Prognostic Marker of Early-Stage Lung Adenocarcinoma Identified by Whole Genome Copy Number Analysis
Reika Iwakawa et al.
CLINICAL CANCER RESEARCH (2011)
Genetics of Parkinson's disease and essential tremor
Alexander Zimprich
CURRENT OPINION IN NEUROLOGY (2011)
Mechanisms of Genomic Instabilities Underlying Two Common Fragile-Site-Associated Loci, PARK2 and DMD, in Germ Cell and Cancer Cell Lines
Jun Mitsui et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
A Genome-Wide Screen for Microdeletions Reveals Disruption of Polarity Complex Genes in Diverse Human Cancers
S. Michael Rothenberg et al.
CANCER RESEARCH (2010)
Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma
Reika Iwakawa et al.
CANCER SCIENCE (2010)
Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis
S. Michael Rothenberg et al.
CURRENT GENOMICS (2010)
Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
Karen Nuytemans et al.
HUMAN MUTATION (2010)
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies
Selvaraju Veeriah et al.
NATURE GENETICS (2010)
Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing
Hansoo Park et al.
NATURE GENETICS (2010)
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2
D. M. Kay et al.
NEUROLOGY (2010)
Genetic determinants at the interface of cancer and neurodegenerative disease
L. G. T. Morris et al.
ONCOGENE (2010)
Hotspots of Large Rare Deletions in the Human Genome
W. Edward C. Bradley et al.
PLOS ONE (2010)
PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice
George Poulogiannis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequency of heterozygous Parkin mutations in healthy subjects: Need for careful prospective follow-up examination of mutation carriers
Norbert Brueggemann et al.
PARKINSONISM & RELATED DISORDERS (2009)
Integrated detection and population-genetic analysis of SNPs and copy number variation
Steven A. McCarroll et al.
NATURE GENETICS (2008)
Progress in the pathogenesis and genetics of Parkinson's disease
Yoshikuni Mizuno et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2008)
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays
Go Yamamoto et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
A. Letessier et al.
ONCOGENE (2007)
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays
Y Nannya et al.
CANCER RESEARCH (2005)
Geographic and ethnic differences in frequencies of two polymorphisms (D/N394 and L/I272) of the parkin gene in sporadic Parkinson's disease
XB Li et al.
PARKINSONISM & RELATED DISORDERS (2005)
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer
MC Picchio et al.
CLINICAL CANCER RESEARCH (2004)
Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 (Publication with Expression of Concern. See vol. 114, 2017)
R Cesari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Parkin variants in north American Parkinson's disease: Cases and controls
SJ Lincoln et al.
MOVEMENT DISORDERS (2003)
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
H Shimura et al.
NATURE GENETICS (2000)
Share Paper
